Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$1.6M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 6 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 39 most recent Form 4 transactions.
| $9.1K |
| -2.3% |
| Open the original filing on SEC.gov |
| Apr 1 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 2,200 | $29.32 | $64.5K | -14.2% | Open the original filing on SEC.gov |
| Apr 1 | MAZE | Maze Therapeutics, Inc. | MEXER◷ | 2,500 | $10.42 | $26.1K | +19.3% | Open the original filing on SEC.gov |
| Mar 2 | MAZE | Maze Therapeutics, Inc. | AGRANT◷◆ | 16,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 2 | MAZE | Maze Therapeutics, Inc. | AGRANT◷◆ | 32,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 2 | MAZE | Maze Therapeutics, Inc. | MEXER◷◆ | 5,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 2 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 3,700 | $45.47 | $168.2K | -22.2% | Open the original filing on SEC.gov |
| Mar 2 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 1,300 | $44.44 | $57.8K | -7.2% | Open the original filing on SEC.gov |
| Mar 2 | MAZE | Maze Therapeutics, Inc. | MEXER◷ | 5,000 | $10.42 | $52.1K | +38.6% | Open the original filing on SEC.gov |
| Feb 2 | MAZE | Maze Therapeutics, Inc. | MEXER◷◆ | 156 | — | — | — | Open the original filing on SEC.gov |
| Feb 2 | MAZE | Maze Therapeutics, Inc. | MEXER◷◆ | 4,844 | — | — | — | Open the original filing on SEC.gov |
| Feb 2 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 736 | $46.63 | $34.3K | -5.4% | Open the original filing on SEC.gov |
| Feb 2 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 4,064 | $46.03 | $187.1K | -22.9% | Open the original filing on SEC.gov |
| Feb 2 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 200 | $44.15 | $8.8K | -1.1% | Open the original filing on SEC.gov |
| Feb 2 | MAZE | Maze Therapeutics, Inc. | MEXER◷ | 156 | $10.42 | $1.6K | +0.9% | Open the original filing on SEC.gov |
| Feb 2 | MAZE | Maze Therapeutics, Inc. | MEXER◷ | 4,844 | $10.42 | $50.5K | +37.4% | Open the original filing on SEC.gov |
| Jan 22 | MAZE | Maze Therapeutics, Inc. | MEXER◷◆ | 2,503 | — | — | — | Open the original filing on SEC.gov |
| Jan 22 | MAZE | Maze Therapeutics, Inc. | MEXER◷◆ | 2,497 | — | — | — | Open the original filing on SEC.gov |
| Jan 22 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 5,000 | $45.52 | $227.6K | -27.8% | Open the original filing on SEC.gov |
| Jan 22 | MAZE | Maze Therapeutics, Inc. | MEXER◷ | 2,503 | $10.42 | $26.1K | +16.2% | Open the original filing on SEC.gov |
| Jan 22 | MAZE | Maze Therapeutics, Inc. | MEXER◷ | 2,497 | $10.42 | $26K | +19.3% | Open the original filing on SEC.gov |
| Jan 2 | MAZE | Maze Therapeutics, Inc. | MEXER◷◆ | 4,796 | — | — | — | Open the original filing on SEC.gov |
| Jan 2 | MAZE | Maze Therapeutics, Inc. | MEXER◷◆ | 204 | — | — | — | Open the original filing on SEC.gov |
| Jan 2 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 2,595 | $39.57 | $102.7K | -16.7% | Open the original filing on SEC.gov |
| Jan 2 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 2,405 | $38.70 | $93.1K | -13.4% | Open the original filing on SEC.gov |
| Jan 2 | MAZE | Maze Therapeutics, Inc. | MEXER◷ | 4,796 | $10.42 | $50K | +36.4% | Open the original filing on SEC.gov |
| Jan 2 | MAZE | Maze Therapeutics, Inc. | MEXER◷ | 204 | $10.42 | $2.1K | +1.6% | Open the original filing on SEC.gov |
| Dec 30, 2025 | MAZE | Maze Therapeutics, Inc. | MEXER◷◆ | 2,605 | — | — | — | Open the original filing on SEC.gov |
| Dec 30, 2025 | MAZE | Maze Therapeutics, Inc. | MEXER◷◆ | 2,395 | — | — | — | Open the original filing on SEC.gov |
| Dec 30, 2025 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 5,000 | $40.08 | $200.4K | -27.8% | Open the original filing on SEC.gov |
| Dec 30, 2025 | MAZE | Maze Therapeutics, Inc. | MEXER◷ | 2,605 | $10.42 | $27.1K | +17.0% | Open the original filing on SEC.gov |
| Dec 30, 2025 | MAZE | Maze Therapeutics, Inc. | MEXER◷ | 2,395 | $10.42 | $25K | +18.5% | Open the original filing on SEC.gov |
| Dec 29, 2025 | MAZE | Maze Therapeutics, Inc. | MEXER◷◆ | 9,876 | — | — | — | Open the original filing on SEC.gov |
| Dec 29, 2025 | MAZE | Maze Therapeutics, Inc. | MEXER◷◆ | 124 | — | — | — | Open the original filing on SEC.gov |
| Dec 29, 2025 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 600 | $41.16 | $24.7K | -4.4% | Open the original filing on SEC.gov |
| Dec 29, 2025 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 9,400 | $40.54 | $381.1K | -40.9% | Open the original filing on SEC.gov |
| Dec 29, 2025 | MAZE | Maze Therapeutics, Inc. | MEXER◷ | 9,876 | $10.42 | $102.9K | +75.4% | Open the original filing on SEC.gov |
| Dec 29, 2025 | MAZE | Maze Therapeutics, Inc. | MEXER◷ | 124 | $10.42 | $1.3K | +1.0% | Open the original filing on SEC.gov |